Seer (SEER) Assets Average (2021 - 2026)
Seer (SEER) posted quarterly Assets Average of $284.1 million for Q1 2026, down 20.4% year-over-year from $356.9 million in Q1 2025, and down 6.03% quarter-over-quarter from $302.3 million in Q4 2025.
Seer (SEER) Assets Average (2021 - 2026) Analysis & Trends
Seer's Assets Average history runs 6 years deep, the most recent figure standing at $284.1 million for Q1 2026.
- In Q1 2026, Assets Average fell 20.4% year-over-year to $284.1 million; the TTM figure through Mar 2026 stood at $284.1 million (down 20.4% YoY), while the FY2025 annual figure was $331.3 million, down 17.46% from the prior year.
- Assets Average for Q1 2026 stood at $284.1 million, down from $302.3 million in the prior quarter.
- The five-year high for Assets Average was $533.1 million in Q1 2022, with the low at $284.1 million in Q1 2026.
- The 5-year median for Assets Average is $429.1 million (2024), against an average of $418.0 million.
- The sharpest annual moves came in 2022 and 2026: Assets Average advanced 7.92% in 2022, then dropped 20.4% in 2026.
- Seer's Assets Average stood at $494.1 million in 2022, then retreated by 10.83% to $440.6 million in 2023, then decreased by 14.88% to $375.0 million in 2024, then dropped by 19.38% to $302.3 million in 2025, then retreated by 6.03% to $284.1 million in 2026.
- Business Quant data shows SEER's Assets Average at $284.1 million in Q1 2026, $302.3 million in Q4 2025, and $315.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | 264.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 264.39 Mn |
| Mar 31, 2026 | 284.11 Mn |
| Dec 31, 2025 | 302.35 Mn |
| Sep 30, 2025 | 315.55 Mn |
| Jun 30, 2025 | 334.87 Mn |
| Mar 31, 2025 | 356.93 Mn |
| Dec 31, 2024 | 375.01 Mn |
| Sep 30, 2024 | 395.02 Mn |
| Jun 30, 2024 | 414.29 Mn |
| Mar 31, 2024 | 429.12 Mn |
| Dec 31, 2023 | 440.56 Mn |
| Sep 30, 2023 | 453.02 Mn |
| Jun 30, 2023 | 466.99 Mn |
| Mar 31, 2023 | 480.36 Mn |
| Dec 31, 2022 | 494.07 Mn |
| Sep 30, 2022 | 508.26 Mn |
| Jun 30, 2022 | 521.69 Mn |
| Mar 31, 2022 | 533.11 Mn |
| Dec 31, 2021 | 533.49 Mn |
| Sep 30, 2021 | 532.44 Mn |